Tuesday, February 9, 2010

Skin Cancer Home>
News>
Qutenza approved for post-shingles pain

Font size
- A
- A
- A
Email This

Bookmark

Save

Qutenza approved for post-shingles pain

(MedicineNet.com) UPDATED 2009-11-17

The U.S. Food and Drug Administration has approved a new skin patch called Qutenza to treat postherpetic neuralgia, the nerve pain that may follow shingles. The active ingredient in Qutenza is synthetic capsaicin, a substance found in chili pepper. The patch delivers the drug to the skin where the nerve pain is felt. Read full story >

See all Skin Cancer News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2010. The HealthCentral Network, Inc. All rights reserved.